Rallybio Corp (RLYB)
NGS · Common · CUSIP 75120L100
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for RLYB and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
75120L100
Market Cap
Small Cap
Business: Rallybio Corp is a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases. The Company’s mission is being advanced by a team of highly experienced biopharma industry leaders with extensive research, development, and rare disease expertise.

Company Contact

CEO
Martin W. Macka
CFO
Jonathan I. Lieber
Headquarters
234 Church Street, Suite 1020, New Haven, CT 06510
Phone
203-859-3820
Investor Relations
Ami Bavishi · 609-477-4536 · investors@Rallybio.com
General Email
info@rallybio.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »